St. Louis Financial Planners Asset Management LLC Makes New $3.10 Million Investment in Intuitive Surgical, Inc. $ISRG

St. Louis Financial Planners Asset Management LLC bought a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 8,215 shares of the medical equipment provider’s stock, valued at approximately $3,098,000. Intuitive Surgical makes up 1.3% of St. Louis Financial Planners Asset Management LLC’s portfolio, making the stock its 25th biggest position.

Several other hedge funds and other institutional investors have also made changes to their positions in ISRG. Bank of New York Mellon Corp acquired a new stake in Intuitive Surgical in the 2nd quarter valued at $1,335,753,000. Arrowstreet Capital Limited Partnership lifted its stake in shares of Intuitive Surgical by 95.3% during the first quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock worth $970,635,000 after purchasing an additional 1,027,475 shares in the last quarter. Invesco Ltd. lifted its stake in shares of Intuitive Surgical by 17.4% during the fourth quarter. Invesco Ltd. now owns 4,128,735 shares of the medical equipment provider’s stock worth $2,338,350,000 after purchasing an additional 611,268 shares in the last quarter. Assenagon Asset Management S.A. lifted its stake in shares of Intuitive Surgical by 55.8% during the third quarter. Assenagon Asset Management S.A. now owns 1,557,940 shares of the medical equipment provider’s stock worth $633,505,000 after purchasing an additional 558,099 shares in the last quarter. Finally, Employees Provident Fund Board purchased a new stake in shares of Intuitive Surgical in the fourth quarter worth about $248,368,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, EVP Gary Loeb sold 400 shares of Intuitive Surgical stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $379.00, for a total transaction of $151,600.00. Following the sale, the executive vice president directly owned 5,320 shares in the company, valued at $2,016,280. The trade was a 6.99% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Mark Brosius sold 77 shares of the company’s stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $375.57, for a total value of $28,918.89. Following the completion of the transaction, the executive vice president directly owned 881 shares in the company, valued at approximately $330,877.17. The trade was a 8.04% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 12,370 shares of company stock valued at $4,891,989 in the last three months. 0.60% of the stock is currently owned by company insiders.

Intuitive Surgical Stock Down 0.3%

Shares of Intuitive Surgical stock traded down $1.16 during trading hours on Friday, hitting $426.70. 2,609,555 shares of the company’s stock traded hands, compared to its average volume of 2,090,678. The stock has a 50 day simple moving average of $391.43 and a 200-day simple moving average of $409.74. The company has a market cap of $150.74 billion, a PE ratio of 48.88, a PEG ratio of 3.23 and a beta of 1.46. Intuitive Surgical, Inc. has a twelve month low of $328.57 and a twelve month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.48 by $0.32. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%. The business had revenue of $2.89 billion for the quarter, compared to analyst estimates of $2.83 billion. During the same period in the previous year, the company earned $1.81 earnings per share. The company’s revenue for the quarter was up 18.4% compared to the same quarter last year. As a group, equities research analysts predict that Intuitive Surgical, Inc. will post 8.87 EPS for the current year.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the company. Robert W. Baird lowered their target price on Intuitive Surgical from $525.00 to $500.00 and set an “outperform” rating for the company in a research note on Friday, July 17th. Stifel Nicolaus reduced their price target on Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating on the stock in a research report on Friday, July 17th. Wall Street Zen lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Sunday, September 20th. TD Cowen cut Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Tuesday, July 28th. Finally, Piper Sandler restated an “overweight” rating on shares of Intuitive Surgical in a report on Friday, August 21st. One analyst has rated the stock with a Strong Buy rating, twenty-two have given a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus target price of $498.83.

Key Stories Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Analysts at Erste Group Bank raised their earnings estimates for ISRG, suggesting improved expectations for the company’s upcoming results and longer-term profitability. Erste Group Bank Analysts Boost Earnings Estimates for ISRG
• Positive Sentiment: Recent results have shown double-digit growth in robotic-surgery procedures, revenue and Intuitive Surgical’s installed base of systems. That underlying operating momentum remains a key support for the investment case despite the stock’s broader underperformance this year. Intuitive Surgical Valuation and Growth
• Positive Sentiment: The shares increased in the prior session and outperformed the broader market that day, reflecting some investor support ahead of the earnings release. ISRG Beats Stock Market Upswing
• Neutral Sentiment: Investors are focused on third-quarter procedure growth, da Vinci system demand, revenue, margins and other operating metrics—not just earnings per share and revenue—to determine whether recent momentum is sustainable. ISRG Ahead of Q3 Earnings
• Negative Sentiment: Expectations are tempered by slowing U.S. procedure growth and headwinds in China. These issues could pressure system placements and margins, increasing the risk of an earnings-related market reaction. ISRG Q3 Earnings Preview
• Negative Sentiment: Despite double-digit growth, shares have declined substantially during 2026 and trade at a premium valuation. Investors are questioning whether a valuation around 33 times expected earnings adequately reflects the company’s growth prospects, particularly if procedure growth slows. ISRG Valuation Analysis

Intuitive Surgical Profile

Intuitive Surgical, Inc develops and commercializes robotic-assisted systems and related technologies designed to support minimally invasive medical procedures. The company’s products are intended to help surgeons perform operations through small incisions while providing enhanced visualization, precision, and control.

Its principal product is the da Vinci Surgical System, a platform used across a range of specialties, including general surgery, urology, gynecology, thoracic surgery, and cardiac procedures.